|
chr11_+_129445002
|
1.497
|
|
APLP2
|
amyloid beta (A4) precursor-like protein 2
|
|
chr11_+_129445017
|
1.492
|
|
APLP2
|
amyloid beta (A4) precursor-like protein 2
|
|
chr11_+_129444997
|
1.293
|
|
APLP2
|
amyloid beta (A4) precursor-like protein 2
|
|
chr22_-_18309447
|
1.271
|
|
TXNRD2
|
thioredoxin reductase 2
|
|
chr11_+_129444877
|
1.226
|
NM_001142276
NM_001142277
NM_001142278
NM_001642
|
APLP2
|
amyloid beta (A4) precursor-like protein 2
|
|
chr4_-_57671307
|
1.203
|
|
IGFBP7
|
insulin-like growth factor binding protein 7
|
|
chr6_+_31976754
|
1.132
|
NM_001178063
|
C2
|
complement component 2
|
|
chr6_+_148705646
|
1.109
|
|
SASH1
|
SAM and SH3 domain containing 1
|
|
chr6_+_148705421
|
1.082
|
NM_015278
|
SASH1
|
SAM and SH3 domain containing 1
|
|
chr15_-_50375143
|
1.065
|
NM_018728
|
MYO5C
|
myosin VC
|
|
chr22_-_18309333
|
1.027
|
NM_006440
|
TXNRD2
|
thioredoxin reductase 2
|
|
chr10_+_115428924
|
1.019
|
NM_033340
|
CASP7
|
caspase 7, apoptosis-related cysteine peptidase
|
|
chr7_+_45894480
|
0.990
|
NM_000596
|
IGFBP1
|
insulin-like growth factor binding protein 1
|
|
chr22_-_18309250
|
0.978
|
|
TXNRD2
|
thioredoxin reductase 2
|
|
chr6_+_7486836
|
0.960
|
|
DSP
|
desmoplakin
|
|
chr16_+_54072969
|
0.937
|
NM_001127891
|
MMP2
|
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase)
|
|
chr18_+_53862744
|
0.936
|
|
NEDD4L
|
neural precursor cell expressed, developmentally down-regulated 4-like
|
|
chr6_+_7486891
|
0.924
|
|
DSP
|
desmoplakin
|
|
chr11_-_116213511
|
0.924
|
NM_000039
|
APOA1
|
apolipoprotein A-I
|
|
chr6_+_7486862
|
0.920
|
NM_001008844
NM_004415
|
DSP
|
desmoplakin
|
|
chr17_-_72218535
|
0.901
|
NM_001008528
NM_001008529
NM_198530
|
MXRA7
|
matrix-remodelling associated 7
|
|
chr1_-_94475504
|
0.897
|
|
ARHGAP29
|
Rho GTPase activating protein 29
|
|
chr17_+_77261477
|
0.864
|
|
HGS
|
hepatocyte growth factor-regulated tyrosine kinase substrate
|
|
chr18_+_53862888
|
0.864
|
|
NEDD4L
|
neural precursor cell expressed, developmentally down-regulated 4-like
|
|
chr18_+_53862386
|
0.845
|
NM_001144967
NM_015277
|
NEDD4L
|
neural precursor cell expressed, developmentally down-regulated 4-like
|
|
chr1_-_94475840
|
0.826
|
NM_004815
|
ARHGAP29
|
Rho GTPase activating protein 29
|
|
chr6_-_47385313
|
0.825
|
|
TNFRSF21
|
tumor necrosis factor receptor superfamily, member 21
|
|
chr16_+_64958025
|
0.823
|
NM_001795
|
CDH5
|
cadherin 5, type 2 (vascular endothelium)
|
|
chr9_-_73573121
|
0.793
|
NM_001135820
NM_013390
|
TMEM2
|
transmembrane protein 2
|
|
chr21_+_41461924
|
0.790
|
|
BACE2
|
beta-site APP-cleaving enzyme 2
|
|
chr13_+_109757593
|
0.763
|
NM_001846
|
COL4A2
|
collagen, type IV, alpha 2
|
|
chr19_-_18578631
|
0.760
|
NM_004750
|
CRLF1
|
cytokine receptor-like factor 1
|
|
chr7_-_47588160
|
0.751
|
|
TNS3
|
tensin 3
|
|
chr7_-_47588266
|
0.728
|
|
TNS3
|
tensin 3
|
|
chr17_+_77261440
|
0.724
|
|
HGS
|
hepatocyte growth factor-regulated tyrosine kinase substrate
|
|
chr4_+_184257337
|
0.720
|
NM_024949
|
WWC2
|
WW and C2 domain containing 2
|
|
chr17_+_77261447
|
0.719
|
|
HGS
|
hepatocyte growth factor-regulated tyrosine kinase substrate
|
|
chr6_+_17501589
|
0.707
|
NM_006366
|
CAP2
|
CAP, adenylate cyclase-associated protein, 2 (yeast)
|
|
chr19_-_18578577
|
0.704
|
|
CRLF1
|
cytokine receptor-like factor 1
|
|
chr19_-_18578467
|
0.698
|
|
CRLF1
|
cytokine receptor-like factor 1
|
|
chr13_-_102249263
|
0.689
|
NM_024089
|
KDELC1
|
KDEL (Lys-Asp-Glu-Leu) containing 1
|
|
chrX_+_117745551
|
0.687
|
NM_001560
|
IL13RA1
|
interleukin 13 receptor, alpha 1
|
|
chr19_-_11234117
|
0.674
|
NM_020812
|
DOCK6
|
dedicator of cytokinesis 6
|
|
chr6_-_47385205
|
0.673
|
|
TNFRSF21
|
tumor necrosis factor receptor superfamily, member 21
|
|
chr1_+_167342149
|
0.662
|
|
ATP1B1
|
ATPase, Na+/K+ transporting, beta 1 polypeptide
|
|
chr2_-_1727247
|
0.658
|
|
PXDN
|
peroxidasin homolog (Drosophila)
|
|
chr12_-_123023312
|
0.658
|
|
CCDC92
|
coiled-coil domain containing 92
|
|
chr2_-_1727324
|
0.656
|
|
PXDN
|
peroxidasin homolog (Drosophila)
|
|
chr17_+_77261401
|
0.654
|
NM_004712
|
HGS
|
hepatocyte growth factor-regulated tyrosine kinase substrate
|
|
chr11_-_82289006
|
0.654
|
NM_005040
NM_199418
|
PRCP
|
prolylcarboxypeptidase (angiotensinase C)
|
|
chr2_+_236067424
|
0.645
|
NM_001037131
NM_014914
|
AGAP1
|
ArfGAP with GTPase domain, ankyrin repeat and PH domain 1
|
|
chr19_+_54707739
|
0.638
|
|
FCGRT
|
Fc fragment of IgG, receptor, transporter, alpha
|
|
chr11_-_2118916
|
0.637
|
NM_001127598
|
IGF2
|
insulin-like growth factor 2 (somatomedin A)
|
|
chr22_-_36245155
|
0.636
|
NM_014550
|
CARD10
|
caspase recruitment domain family, member 10
|
|
chr2_+_187162969
|
0.636
|
NM_001145000
NM_002210
|
ITGAV
|
integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51)
|
|
chr17_+_71893014
|
0.621
|
|
SPHK1
|
sphingosine kinase 1
|
|
chr11_+_129445057
|
0.620
|
|
APLP2
|
amyloid beta (A4) precursor-like protein 2
|
|
chr21_+_41461962
|
0.616
|
|
BACE2
|
beta-site APP-cleaving enzyme 2
|
|
chr16_+_55217085
|
0.611
|
NM_175617
|
MT1E
|
metallothionein 1E
|
|
chr6_+_148705817
|
0.609
|
|
SASH1
|
SAM and SH3 domain containing 1
|
|
chr17_+_71892538
|
0.608
|
|
SPHK1
|
sphingosine kinase 1
|
|
chr17_+_71892271
|
0.605
|
NM_001142601
NM_021972
NM_182965
|
SPHK1
|
sphingosine kinase 1
|
|
chr9_+_136673464
|
0.601
|
NM_000093
|
COL5A1
|
collagen, type V, alpha 1
|
|
chr13_-_109757442
|
0.599
|
NM_001845
|
COL4A1
|
collagen, type IV, alpha 1
|
|
chr7_-_50828159
|
0.595
|
|
GRB10
|
growth factor receptor-bound protein 10
|
|
chr10_+_129595289
|
0.591
|
NM_006504
|
PTPRE
|
protein tyrosine phosphatase, receptor type, E
|
|
chr2_-_101134146
|
0.582
|
NM_001102426
|
TBC1D8
|
TBC1 domain family, member 8 (with GRAM domain)
|
|
chr9_-_83493415
|
0.579
|
NM_005077
|
TLE1
|
transducin-like enhancer of split 1 (E(sp1) homolog, Drosophila)
|
|
chr16_+_81218074
|
0.578
|
NM_001257
|
CDH13
|
cadherin 13, H-cadherin (heart)
|
|
chr12_-_123023052
|
0.570
|
NM_025140
|
CCDC92
|
coiled-coil domain containing 92
|
|
chr4_-_122837501
|
0.562
|
|
ANXA5
|
annexin A5
|
|
chr3_+_52504391
|
0.561
|
NM_015136
|
STAB1
|
stabilin 1
|
|
chr21_+_45649719
|
0.560
|
|
|
|
|
chr10_-_126839546
|
0.558
|
NM_001083914
|
CTBP2
|
C-terminal binding protein 2
|
|
chr4_-_122837590
|
0.557
|
NM_001154
|
ANXA5
|
annexin A5
|
|
chr17_-_3518654
|
0.556
|
NM_014604
|
TAX1BP3
|
Tax1 (human T-cell leukemia virus type I) binding protein 3
|
|
chr17_+_71892781
|
0.556
|
NM_001142602
|
SPHK1
|
sphingosine kinase 1
|
|
chr7_-_27190882
|
0.550
|
|
HOXA11
|
homeobox A11
|
|
chr11_+_822965
|
0.540
|
|
CD151
|
CD151 molecule (Raph blood group)
|
|
chr4_-_40911212
|
0.538
|
NM_001166050
NM_004307
NM_173075
|
APBB2
|
amyloid beta (A4) precursor protein-binding, family B, member 2
|
|
chr11_+_67836575
|
0.536
|
NM_002335
|
LRP5
|
low density lipoprotein receptor-related protein 5
|
|
chr5_+_150380325
|
0.533
|
|
GPX3
|
glutathione peroxidase 3 (plasma)
|
|
chr4_+_4912272
|
0.532
|
NM_002448
|
MSX1
|
msh homeobox 1
|
|
chr3_+_52464657
|
0.532
|
|
NISCH
|
nischarin
|
|
chr4_-_122837579
|
0.532
|
|
ANXA5
|
annexin A5
|
|
chr5_+_150380270
|
0.529
|
|
GPX3
|
glutathione peroxidase 3 (plasma)
|
|
chr12_+_50631704
|
0.528
|
NM_004302
NM_020328
|
ACVR1B
|
activin A receptor, type IB
|
|
chr17_+_72648580
|
0.518
|
NM_001039573
NM_001143998
NM_001143999
NM_003003
|
SEC14L1
|
SEC14-like 1 (S. cerevisiae)
|
|
chr19_+_40242634
|
0.517
|
|
HPN
|
hepsin
|
|
chr22_+_42651007
|
0.501
|
|
PNPLA3
|
patatin-like phospholipase domain containing 3
|
|
chr5_+_150380173
|
0.501
|
NM_002084
|
GPX3
|
glutathione peroxidase 3 (plasma)
|
|
chr22_+_42650951
|
0.501
|
NM_025225
|
PNPLA3
|
patatin-like phospholipase domain containing 3
|
|
chr16_+_8675904
|
0.496
|
NM_020686
|
ABAT
|
4-aminobutyrate aminotransferase
|
|
chr11_-_63138516
|
0.494
|
NM_001128203
|
PLA2G16
|
phospholipase A2, group XVI
|
|
chr22_+_42651018
|
0.492
|
|
PNPLA3
|
patatin-like phospholipase domain containing 3
|
|
chr11_-_63138061
|
0.491
|
|
PLA2G16
|
phospholipase A2, group XVI
|
|
chr11_-_63138483
|
0.486
|
NM_007069
|
PLA2G16
|
phospholipase A2, group XVI
|
|
chr11_-_63138416
|
0.485
|
|
PLA2G16
|
phospholipase A2, group XVI
|
|
chr17_-_72218661
|
0.485
|
|
MXRA7
|
matrix-remodelling associated 7
|
|
chr2_-_1727292
|
0.483
|
NM_012293
|
PXDN
|
peroxidasin homolog (Drosophila)
|
|
chr19_+_54708247
|
0.482
|
NM_004107
|
FCGRT
|
Fc fragment of IgG, receptor, transporter, alpha
|
|
chr12_-_120810899
|
0.478
|
NM_001171993
|
HPD
|
4-hydroxyphenylpyruvate dioxygenase
|
|
chr19_+_40224457
|
0.476
|
|
HPN
|
hepsin
|
|
chr7_+_93976927
|
0.476
|
NM_022900
|
CASD1
|
CAS1 domain containing 1
|
|
chr21_+_17807167
|
0.472
|
NM_001338
|
CXADR
|
coxsackie virus and adenovirus receptor
|
|
chr19_+_47521600
|
0.471
|
NM_001410
|
MEGF8
|
multiple EGF-like-domains 8
|
|
chr17_-_3518568
|
0.466
|
|
TAX1BP3
|
Tax1 (human T-cell leukemia virus type I) binding protein 3
|
|
chr5_-_141041933
|
0.465
|
|
ARAP3
|
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3
|
|
chr9_+_123003549
|
0.463
|
|
GSN
|
gelsolin
|
|
chr19_+_54708302
|
0.461
|
|
FCGRT
|
Fc fragment of IgG, receptor, transporter, alpha
|
|
chr17_+_72648696
|
0.460
|
|
SEC14L1
|
SEC14-like 1 (S. cerevisiae)
|
|
chr5_-_141041982
|
0.454
|
NM_022481
|
ARAP3
|
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3
|
|
chr7_-_29995809
|
0.453
|
NM_001145515
NM_014766
NM_001145513
|
SCRN1
|
secernin 1
|
|
chr1_-_27113018
|
0.450
|
NM_021969
|
NR0B2
|
nuclear receptor subfamily 0, group B, member 2
|
|
chr5_+_176446425
|
0.448
|
NM_002011
NM_213647
|
FGFR4
|
fibroblast growth factor receptor 4
|
|
chr6_+_7672009
|
0.447
|
NM_001718
|
BMP6
|
bone morphogenetic protein 6
|
|
chr17_-_3518628
|
0.444
|
|
TAX1BP3
|
Tax1 (human T-cell leukemia virus type I) binding protein 3
|
|
chr20_-_61039672
|
0.441
|
|
DIDO1
|
death inducer-obliterator 1
|
|
chr2_+_219354692
|
0.441
|
NM_000784
|
CYP27A1
|
cytochrome P450, family 27, subfamily A, polypeptide 1
|
|
chr2_+_218992053
|
0.433
|
NM_007127
|
VIL1
|
villin 1
|
|
chr7_-_50828608
|
0.428
|
NM_001001555
|
GRB10
|
growth factor receptor-bound protein 10
|
|
chr19_+_40224480
|
0.421
|
|
HPN
|
hepsin
|
|
chr6_-_47385470
|
0.416
|
|
TNFRSF21
|
tumor necrosis factor receptor superfamily, member 21
|
|
chr1_+_181259317
|
0.412
|
|
|
|
|
chr9_-_14303509
|
0.412
|
|
NFIB
|
nuclear factor I/B
|
|
chr2_-_242096673
|
0.410
|
NM_006374
|
STK25
|
serine/threonine kinase 25
|
|
chr20_-_23566325
|
0.409
|
NM_000099
|
CST3
|
cystatin C
|
|
chr17_+_19377732
|
0.403
|
NM_018242
|
SLC47A1
|
solute carrier family 47, member 1
|
|
chr7_+_73506047
|
0.403
|
NM_016328
|
GTF2IRD1
|
GTF2I repeat domain containing 1
|
|
chr19_+_54708312
|
0.402
|
|
FCGRT
|
Fc fragment of IgG, receptor, transporter, alpha
|
|
chr2_-_224612177
|
0.398
|
NM_001136528
NM_006216
|
SERPINE2
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2
|
|
chr9_-_13269562
|
0.398
|
|
MPDZ
|
multiple PDZ domain protein
|
|
chr6_+_107917965
|
0.398
|
NM_018013
|
SOBP
|
sine oculis binding protein homolog (Drosophila)
|
|
chr2_-_20714303
|
0.397
|
NM_022460
|
HS1BP3
|
HCLS1 binding protein 3
|
|
chr14_+_73073570
|
0.397
|
NM_001037161
|
ACOT1
|
acyl-CoA thioesterase 1
|
|
chr7_+_93977267
|
0.395
|
|
CASD1
|
CAS1 domain containing 1
|
|
chr17_-_75808680
|
0.393
|
NM_000199
|
SGSH
|
N-sulfoglucosamine sulfohydrolase
|
|
chr1_+_149779384
|
0.392
|
NM_001126337
NM_020127
|
TUFT1
|
tuftelin 1
|
|
chr22_-_18309312
|
0.384
|
|
TXNRD2
|
thioredoxin reductase 2
|
|
chr18_+_53967544
|
0.383
|
NM_001144965
NM_001144968
NM_001144969
NM_001144971
|
NEDD4L
|
neural precursor cell expressed, developmentally down-regulated 4-like
|
|
chr2_+_85213884
|
0.381
|
NM_031283
|
TCF7L1
|
transcription factor 7-like 1 (T-cell specific, HMG-box)
|
|
chr5_+_79739548
|
0.378
|
NM_001105251
NM_014733
|
ZFYVE16
|
zinc finger, FYVE domain containing 16
|
|
chr9_+_96528764
|
0.374
|
NM_001193331
NM_032823
|
C9orf3
|
chromosome 9 open reading frame 3
|
|
chr13_+_112670757
|
0.374
|
NM_001112732
|
MCF2L
|
MCF.2 cell line derived transforming sequence-like
|
|
chr22_+_36632242
|
0.374
|
NM_033386
|
MICALL1
|
MICAL-like 1
|
|
chr9_+_96528814
|
0.370
|
|
C9orf3
|
chromosome 9 open reading frame 3
|
|
chr2_-_242096592
|
0.364
|
|
STK25
|
serine/threonine kinase 25
|
|
chr2_-_21079145
|
0.360
|
|
APOB
|
apolipoprotein B (including Ag(x) antigen)
|
|
chr14_+_105012106
|
0.356
|
NM_001312
|
CRIP2
|
cysteine-rich protein 2
|
|
chr9_-_139202831
|
0.354
|
|
ANAPC2
|
anaphase promoting complex subunit 2
|
|
chr11_-_72031083
|
0.351
|
NM_001143839
|
PDE2A
|
phosphodiesterase 2A, cGMP-stimulated
|
|
chr4_-_89299034
|
0.350
|
NM_004827
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2
|
|
chr2_-_242096122
|
0.350
|
|
STK25
|
serine/threonine kinase 25
|
|
chr6_-_47385605
|
0.344
|
NM_014452
|
TNFRSF21
|
tumor necrosis factor receptor superfamily, member 21
|
|
chr9_-_139202855
|
0.342
|
NM_013366
|
ANAPC2
|
anaphase promoting complex subunit 2
|
|
chr19_-_4351357
|
0.342
|
|
SH3GL1
|
SH3-domain GRB2-like 1
|
|
chr12_-_69317441
|
0.341
|
NM_001109754
|
PTPRB
|
protein tyrosine phosphatase, receptor type, B
|
|
chr12_-_105165805
|
0.339
|
NM_006825
|
CKAP4
|
cytoskeleton-associated protein 4
|
|
chr19_+_15079141
|
0.337
|
NM_033025
|
SYDE1
|
synapse defective 1, Rho GTPase, homolog 1 (C. elegans)
|
|
chr13_+_112681626
|
0.337
|
NM_024979
|
MCF2L
|
MCF.2 cell line derived transforming sequence-like
|
|
chr6_-_33374678
|
0.335
|
|
RGL2
|
ral guanine nucleotide dissociation stimulator-like 2
|
|
chr7_+_73506172
|
0.334
|
|
GTF2IRD1
|
GTF2I repeat domain containing 1
|
|
chr8_+_38973681
|
0.325
|
|
ADAM9
|
ADAM metallopeptidase domain 9
|
|
chr5_-_1165106
|
0.324
|
NM_006598
|
SLC12A7
|
solute carrier family 12 (potassium/chloride transporters), member 7
|
|
chr13_+_97593411
|
0.323
|
NM_001001715
NM_005766
|
FARP1
|
FERM, RhoGEF (ARHGEF) and pleckstrin domain protein 1 (chondrocyte-derived)
|
|
chr21_-_45118037
|
0.321
|
NM_004339
|
PTTG1IP
|
pituitary tumor-transforming 1 interacting protein
|
|
chr19_+_54707637
|
0.320
|
|
FCGRT
|
Fc fragment of IgG, receptor, transporter, alpha
|
|
chr3_+_52504410
|
0.320
|
|
STAB1
|
stabilin 1
|
|
chr3_-_173010921
|
0.319
|
NM_001130081
NM_002662
|
PLD1
|
phospholipase D1, phosphatidylcholine-specific
|
|
chr16_-_55876099
|
0.319
|
|
PLLP
|
plasmolipin
|
|
chr2_-_219802482
|
0.315
|
|
ATG9A
|
ATG9 autophagy related 9 homolog A (S. cerevisiae)
|
|
chr18_+_18003401
|
0.314
|
NM_005257
|
GATA6
|
GATA binding protein 6
|
|
chr16_-_55876075
|
0.313
|
NM_015993
|
PLLP
|
plasmolipin
|
|
chr22_+_36927884
|
0.312
|
NM_001161572
NM_001161574
NM_012323
|
MAFF
|
v-maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian)
|
|
chr13_+_112789669
|
0.312
|
|
MCF2L
|
MCF.2 cell line derived transforming sequence-like
|
|
chr17_+_50697355
|
0.312
|
|
HLF
|
hepatic leukemia factor
|
|
chr8_+_38973588
|
0.311
|
NM_003816
|
ADAM9
|
ADAM metallopeptidase domain 9
|
|
chr13_-_27967215
|
0.311
|
NM_001159920
NM_001160030
NM_001160031
NM_002019
|
FLT1
|
fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor)
|
|
chr19_+_50041424
|
0.311
|
|
PVRL2
|
poliovirus receptor-related 2 (herpesvirus entry mediator B)
|
|
chr2_+_36436873
|
0.310
|
NM_016441
|
CRIM1
|
cysteine rich transmembrane BMP regulator 1 (chordin-like)
|
|
chr12_-_78608154
|
0.310
|
|
PAWR
|
PRKC, apoptosis, WT1, regulator
|
|
chr7_-_35044177
|
0.309
|
NM_015283
|
DPY19L1
|
dpy-19-like 1 (C. elegans)
|
|
chr16_+_3055313
|
0.308
|
NM_001012631
NM_001012633
NM_001012718
NM_004221
|
IL32
|
interleukin 32
|
|
chr16_+_55217180
|
0.307
|
|
MT1E
|
metallothionein 1E
|
|
chr2_+_182464713
|
0.307
|
NM_001130445
NM_006751
|
SSFA2
|
sperm specific antigen 2
|
|
chr8_+_123863224
|
0.306
|
|
ZHX2
|
zinc fingers and homeoboxes 2
|
|
chr10_-_52315390
|
0.306
|
|
A1CF
|
APOBEC1 complementation factor
|
|
chr6_-_2916280
|
0.304
|
|
SERPINB6
|
serpin peptidase inhibitor, clade B (ovalbumin), member 6
|
|
chr17_-_34635446
|
0.301
|
NM_198993
|
STAC2
|
SH3 and cysteine rich domain 2
|
|
chr8_+_61753793
|
0.299
|
NM_017780
|
CHD7
|
chromodomain helicase DNA binding protein 7
|
|
chr9_-_110736143
|
0.297
|
|
IKBKAP
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase complex-associated protein
|
|
chr9_-_139202804
|
0.296
|
|
ANAPC2
|
anaphase promoting complex subunit 2
|
|
chr19_+_50041400
|
0.296
|
|
PVRL2
|
poliovirus receptor-related 2 (herpesvirus entry mediator B)
|
|
chr11_+_823007
|
0.294
|
|
CD151
|
CD151 molecule (Raph blood group)
|
|
chr6_-_52549673
|
0.294
|
|
TRAM2
|
translocation associated membrane protein 2
|
|
chr7_+_142789476
|
0.293
|
|
ZYX
|
zyxin
|
|
chr9_-_110736377
|
0.293
|
NM_003640
|
IKBKAP
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase complex-associated protein
|
|
chr8_-_11762918
|
0.289
|
|
CTSB
|
cathepsin B
|
|
chr19_-_18913011
|
0.288
|
|
HOMER3
|
homer homolog 3 (Drosophila)
|
|
chr6_-_52549774
|
0.282
|
NM_012288
|
TRAM2
|
translocation associated membrane protein 2
|
